嘉事堂(002462) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥4,643,590,103.16, representing a year-on-year growth of 25.99%[8] - Net profit attributable to shareholders was ¥74,790,440.55, up 29.94% year-on-year[8] - Basic earnings per share increased to ¥0.30, reflecting a growth of 30.43% compared to the same period last year[8] - The weighted average return on net assets was 3.16%, an increase of 0.43% compared to the previous year[8] - The estimated net profit attributable to shareholders for 2018 is expected to be between 263.64 million yuan and 342.73 million yuan, reflecting a growth of 0.00% to 30.00% compared to the previous year[21] Assets and Liabilities - Total assets at the end of the reporting period reached ¥10,813,987,091.63, an increase of 17.48% compared to the previous year[8] - Accounts receivable decreased by 43.59 million yuan, a reduction of 53.31%, mainly due to the maturity payment of accepted bills during the reporting period[16] - Prepayments increased by 127.99 million yuan, a growth of 69.87%, primarily due to rapid growth in wholesale business and the implementation of the two-invoice system in the pharmaceutical industry[16] - Inventory increased by 435.38 million yuan, a growth of 32.59%, driven by the need to increase stock reserves to support sales due to fast business growth[16] - Short-term borrowings increased by 860.34 million yuan, a growth of 41.59%, as the company borrowed more from banks to support the rapid growth of its wholesale business[16] Cash Flow - The net cash flow from operating activities was -¥112,058,212.07, a decline of 118.42% year-on-year[8] - Net cash flow from operating activities decreased by 752.88 million yuan, a reduction of 235.16%, mainly due to cash inflows from asset-backed notes in the previous year[16] - Net cash flow from investing activities increased by 100.77 million yuan, a growth of 76.69%, due to lower cash outflows from equity acquisitions in the previous year[16] Shareholder Information - The total number of shareholders at the end of the reporting period was 19,152[12] - The largest shareholder, China Youth Industrial Development Corporation, holds 16.72% of the shares[12] - The company did not engage in any repurchase transactions during the reporting period[13] Government Support and Commitments - The company received government subsidies amounting to ¥13,021,666.58 during the reporting period[9] - The company has not experienced any overdue commitments from controlling shareholders or related parties during the reporting period[20] Financial Challenges - Financial expenses increased by 60.45 million yuan, a growth of 84.01%, mainly due to increased interest payments on short-term borrowings and financial costs from issuing asset-backed notes[16] - Asset impairment losses increased by 27.54 million yuan, a growth of 631.70%, primarily due to increased bad debt provisions related to accounts receivable[16]